🇺🇸 FDA
Pipeline program

UB-621

UBP-A228-HSV

Phase 2 mab active

Quick answer

UB-621 for Recurrent Genital Herpes is a Phase 2 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Recurrent Genital Herpes
Phase
Phase 2
Modality
mab
Status
active

Clinical trials